Logo 2900 (Glipizide extended release 10 mg)

Pill imprint Logo 2900 has been identified as Glipizide extended release 10 mg.

Glipizide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glipizide 10 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for Logo 2900 (Glipizide extended release 10 mg)

Glipizide extended release 10 mg Logo 2900  Front
Glipizide extended release 10 mg Logo 2900  Back
Glipizide extended release
Imprint:
Logo 2900
Strength:
10 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Sulfonylureas
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Actavis
National Drug Code (NDC):
00228-2900
Inactive Ingredients:
acetyltributyl citrate
hydroxyethyl cellulose (140 cps at 5%)
hypromellose
hydroxypropyl cellulose
lactose monohydrate
sodium chloride
magnesium stearate
ferric oxide red
methacrylic acid - ethyl acrylate copolymer (1:1) type a
cellulose acetate
polyethylene glycol

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web4)